{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:49:07Z","timestamp":1771044547350,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["NCI-CA129343"],"award-info":[{"award-number":["NCI-CA129343"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.bbrc.2011.08.111","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T10:32:48Z","timestamp":1314613968000},"page":"383-388","source":"Crossref","is-referenced-by-count":16,"title":["Modulation of the ribonucleotide reductase M1\u2013gemcitabine interaction in vivo by N-ethylmaleimide"],"prefix":"10.1016","volume":"413","author":[{"given":"Zhengming","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerold","family":"Bepler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.08.111_b0005","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1126\/science.8511586","article-title":"From RNA to DNA, why so many ribonucleotide reductases?","volume":"260","author":"Reichard","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2011.08.111_b0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/1074-5521(95)90084-5","article-title":"Ribonucleotide reductases: radical enzymes with suicidal tendencies","volume":"2","author":"Stubbe","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2011.08.111_b0015","doi-asserted-by":"crossref","first-page":"13181","DOI":"10.1073\/pnas.94.24.13181","article-title":"The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments","volume":"94","author":"Fan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.08.111_b0020","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/sj.onc.1206232","article-title":"RRM1-induced metastasis suppression through PTEN-regulated pathways","volume":"22","author":"Gautam","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2011.08.111_b0025","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1158\/0008-5472.CAN-05-4462","article-title":"Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase","volume":"66","author":"Gautam","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.08.111_b0030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/bi020634d","article-title":"Comprehensive model for allosteric regulation of mammalian ribonucleotide reductase: refinements and consequences","volume":"42","author":"Kashlan","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.08.111_b0035","doi-asserted-by":"crossref","first-page":"31533","DOI":"10.1074\/jbc.272.50.31533","article-title":"A new mechanism-based radical intermediate in a mutant R1 protein affecting the catalytically essential Glu441 in Escherichia coli ribonucleotide reductase","volume":"272","author":"Persson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.111_b0040","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1074\/jbc.M106538200","article-title":"The conserved active site asparagine in class I ribonucleotide reductase is essential for catalysis","volume":"277","author":"Kasrayan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.111_b0045","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1021\/bi00155a029","article-title":"A model for the role of multiple cysteine residues involved in ribonucleotide reduction: amazing and still confusing","volume":"31","author":"Mao","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.08.111_b0050","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-03-0156","article-title":"Ribonucleotide reductase mRNA expression and survival in gemcitabine\/cisplatin-treated advanced non-small-cell lung cancer patients","volume":"10","author":"Rosell","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2011.08.111_b0055","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1200\/JCO.2006.06.1101","article-title":"RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer","volume":"24","author":"Bepler","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2011.08.111_b0060","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1038\/onc.2009.158","article-title":"Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma","volume":"28","author":"Akita","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2011.08.111_b0065","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2004.12.002","article-title":"RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer","volume":"22","author":"Bepler","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2011.08.111_b0070","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","article-title":"The DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer","volume":"356","author":"Zheng","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2011.08.111_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2217\/14622416.10.1.69","article-title":"Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors","volume":"10","author":"Danesi","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbrc.2011.08.111_b0080","first-page":"3","article-title":"Gemcitabine: preclinical pharmacology and mechanism of action","volume":"23","author":"Plunkett","year":"1996","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbrc.2011.08.111_b0085","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jcc.20054","article-title":"Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine","volume":"25","author":"Pereira","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2011.08.111_b0090","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1021\/bi902132u","article-title":"Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine 5\u2032-triphosphate: covalent modification","volume":"49","author":"Lohman","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.08.111_b0095","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1021\/bi901590q","article-title":"Insight into the mechanism of inactivation of ribonucleotide reductase by gemcitabine 5\u2032-diphosphate in the presence or absence of reductant","volume":"48","author":"Artin","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.08.111_b0100","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1073\/pnas.0706803104","article-title":"Enhanced subunit interactions with gemcitabine-5\u2032-diphosphate inhibits ribonucleotide reductases","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.08.111_b0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1042\/bj0910589","article-title":"Reactions of N-ethylmaleimide with peptides and amino acids","volume":"91","author":"Smyth","year":"1964","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2011.08.111_b0110","doi-asserted-by":"crossref","first-page":"40148","DOI":"10.1074\/jbc.M206376200","article-title":"N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A","volume":"277","author":"Yellaturu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.111_b0115","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M410242200","article-title":"Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification","volume":"280","author":"Humphries","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.111_b0120","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1021\/bi901588z","article-title":"Mechanism of inactivation of human ribonucleotide reductase with p53R2 by gemcitabine 5\u2032-diphosphate","volume":"48","author":"Wang","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.08.111_b0125","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/bi9021318","article-title":"Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine 5\u2032-triphosphate: adenosylcobalamin destruction and formation of a neucleotide-based radical","volume":"49","author":"Lohman","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.08.111_b0130","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1021\/bi992820y","article-title":"Formation of the cystine between cysteine 225 and cysteine 462 from ribonucleoside diphosphate reductase is kinetically competent","volume":"39","author":"Erickson","year":"2000","journal-title":"Biochemistry"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11015208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11015208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T06:52:16Z","timestamp":1543560736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11015208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0006291X11015208"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.08.111","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}